Tuberculosis comorbidities, multimorbidity and mortality amongst adults in South Africa: A prospective cohort study nested in a trial
Open Access
- 5 August 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (8) , e0006720
Abstract
Tuberculosis (TB) comorbidities and multimorbidity - the presence of two or more concurrent diseases or health conditions - are major contributors to TB incidence and mortality. We investigated the prevalence and associated mortality of TB comorbidities and multimorbidity in South Africa. We conducted a prospective cohort study of adults ≥15 years with bacteriologically-confirmed pulmonary TB, nested within a trial in two provinces of South Africa. We investigated five TB key comorbidities (HIV, undernutrition, diabetes, smoking and alcohol use), and assessed all-cause mortality over 15 months using Cox regression. TB comorbidity was defined as TB with one comorbidity, and TB multimorbidity as TB with two or more comorbidities. Of 1997 participants, 1896 (95%) had mortality data available at 15 months. Median age was 38 (IQR 29–48) years, 1203/1997 (60%) were male, 86·2% (95% CI 84·6-86·6) had TB comorbidity and 47·5% (45·3-49·7) had TB multimorbidity. TB comorbidity peaked in participants aged 40–49 years (93% [90–95]), was more prevalent in men vs women (90%[88–91] vs 81%[78–84], p < 0·001), and in urban vs rural areas (88%[86–90] vs 84%[81–86], p = 0·005). Mortality was higher for participants with TB multimorbidity with two (16·0%[13·0-18·8], HR 1·88[1·20-2·95], p = 0·006) and three or more (19·9%[14·9-24·6], HR 2·58[1·56-4·24], p < 0·001) TB key comorbidities than those with no comorbidities (11·2%[7·17-15·0]) or TB comorbidity (10·6% [8·32-12·8]). The joint population attributable fraction for the TB key comorbidities on mortality was 60·0% (49·6-69·2%). TB comorbidities and multimorbidity are highly prevalent and significantly associated with mortality. People with TB should be offered screening and management of comorbidities to reduce their risk of death.Keywords
Funding Information
- South African Medical Research Council (006Newton TB)
- National Institute for Health and Care Research (ACF-2022-07-007)
- Medical Research Council (MR/Y503216/1)
- Medical Research Foundation (MRF-131-0006-RG-KHOS-C0942)
This publication has 28 references indexed in Scilit:
- Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysiseClinicalMedicine, 2024
- Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trialThe Lancet, 2023
- Drivers of sex differences in the South African adult tuberculosis incidence and mortality trends, 1990–2019Scientific Reports, 2023
- Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysisBMJ Open, 2022
- Household Contact Tracing With Intensified Tuberculosis and Human Immunodeficiency Virus Screening in South Africa: A Cluster-Randomized TrialClinical Infectious Diseases, 2021
- Systematic analysis for the relationship between obesity and tuberculosisPublic Health, 2020
- Multimorbidity—a defining challenge for health systemsThe Lancet Public Health, 2019
- Undernutrition and Tuberculosis: Public Health ImplicationsThe Journal of Infectious Diseases, 2018
- Tuberculosis and chronic respiratory disease: a systematic reviewInternational Journal of Infectious Diseases, 2015
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingJournal of the Royal Statistical Society Series B: Statistical Methodology, 1995